GPR78 and non-small cell lung carcinoma: Besides, miR-936 was significantly downregulated in NSCLC cells, and its overexpression inactivated the Galphaq Rho GTPase pathway by targeting GPR78, resulting in the repression of cisplatin resistance in NSCLC cells (157).